Eli Lilly Stock Price Predictions for Investors: Insights and Analysis
Thursday, 31 October 2024, 15:11
Eli Lilly's Earnings Report: A Mixed Bag
Eli Lilly (NYSE: LLY) recently reported earnings that fell short of analyst expectations, revealing an EPS of $1.18 compared to the anticipated $1.47. This poor performance led to a 6.84% decline in LLY stock, which currently sits at $835.92.
Analyst Ratings and Price Target for LLY
- Out of 20 analysts, 18 maintain a 'buy' rating for LLY.
- The average 12-month price target is set at $1,063.29, indicating a potential rise of 28.30%.
- Citi's most bullish estimate predicts LLY could reach $1,250.
Market Sentiment and Future Trends
Despite the recent earnings miss, analysts see potential for growth, primarily attributing the weaknesses to inventory challenges rather than reduced demand. The fact that no sell ratings exist for Eli Lilly shares suggests a strong consensus on the stock's recovery.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.